AI Article Synopsis
- Cervical cancer during pregnancy is uncommon and poses significant challenges for diagnosis and treatment, especially in low-resource settings.
- A case study is presented of a 27-year-old woman diagnosed with FIGO stage IB3 cervical cancer at 28 weeks of pregnancy, who was successfully managed by 37 weeks.
- This report marks the first documented instance of cervical cancer in pregnancy in Bhutan, emphasizing the difficulties faced in health systems with limited resources.
Article Abstract
Background: Cervical cancer in pregnancy is a rare event. Diagnosis and management of cervical cancer in pregnancy is complicated and challenging in a low resource setting.
Case Presentation: Herein, we present a case of cervical cancer (FIGO stage IB3) diagnosed at 28 weeks and successfully managed at 37 weeks of gestation in a 27-year-old woman.
Conclusion: This is the first case report on cervical cancer in pregnancy from Bhutan. It highlights the diagnostic and management challenges in a low resource country.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11391834 | PMC |
| http://dx.doi.org/10.1186/s12884-024-06716-4 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Applying Results of Extended Genotyping to Management of Positive Cervicovaginal Human Papillomavirus Test Results: Enduring Guidelines.
J Low Genit Tract Dis
January 2025
Division of Cancer Epidemiology & Genetics, National Cancer Institute, Rockville, MD.
Objective: The Enduring Consensus Cervical Cancer Screening and Management Guidelines Committee developed recommendations for the use of extended genotyping results in cervical cancer prevention programs.
Methods: Risks of cervical intraepithelial neoplasia grade 3 or worse were calculated using data obtained with the Onclarity HPV Assay from large cohorts. Management recommendations were based on clinical action thresholds developed for the 2019 American Society for Colposcopy and Cervical Pathology Risk-Based Management Consensus Guidelines.
Cytotoxic and antibacterial activity of naturally occurring agglutinin produced from the root of Poir.
Nat Prod Res
January 2025
Bioprocess Engineering Division, Smykon Biotech, Kanniyakumari, Tamilnadu, India.
Lectins are naturally occurring agglutinins which are produced more from plants sources compared to animal sources. The present study aims to screen the potential applications of lectin isolated from the mangrove plant, Poir. This root agglutinin of showed highest HA titre with buffalo erythrocytes.
View Article and Find Full Text PDFInvestigation of Women's Knowledge and Beliefs About Cervical Cancer and Cervical Smear Examination: A Survey Study in Greece.
Cureus
December 2024
Department of Midwifery, University of West Attica, Athens, GRC.
Aim This study aimed to investigate women's knowledge and beliefs about cervical cancer and cervical smear examinations. Methodology The research was conducted at a health center in Greece from May 15, 2023, to August 15, 2023. The study sample consisted of 160 women aged 21-65 years who attended the health center.
View Article and Find Full Text PDFAssessment of Knowledge, Awareness, and Practices of Human Papillomavirus Infection and Vaccination Among Medical and Dental Students: A Cross-Sectional Study.
Cureus
December 2024
Department of Community Medicine, Institute of Medical Sciences and Sum Hospital, Siksha 'O' Anusandhan, Bhubaneswar, IND.
Introduction Human papillomavirus (HPV) is the most common causative agent for cervical cancer (CC) in women. Despite extensive initiatives, the acceptance and implementation of vaccinations have remained inadequate, hindering a significant impact on public health outcomes. This study aimed to provide a comprehensive assessment of the knowledge, awareness, and practices (KAP) scores of medical and dental students regarding HPV infection and vaccination.
View Article and Find Full Text PDFRetraction: Iso-pencillixanthone A from a marine-derived fungus reverses multidrug resistance in cervical cancer cells through down-regulating P-gp and re-activating apoptosis.
RSC Adv
January 2025
Fujian Provincial Key Laboratory of Tumor Biotherapy, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital Fuzhou 350014 P. R. China +86-591-8366-0063.
[This retracts the article DOI: 10.1039/C8RA09506J.].
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!